procainamide has been researched along with Tachycardia, Ventricular in 143 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Procainamide is an antiarrhythmic drug of unproven efficacy in cardiac arrest." | 5.36 | Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest. ( Allen, J; Eisenberg, MS; Fahrenbruch, CE; Gold, LS; Kudenchuk, PJ; Markel, DT; Rea, TD, 2010) |
| "A 70-year-old man, who had sustained ventricular tachycardias following a previous anterior myocardial infarction, suffered from skin eruptions and abnormal blood tests after 10 days following the oral administration of 1500 mg/day of procainamide." | 5.30 | [Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia]. ( Abe, H; Kohshi, K; Nakashima, Y; Numata, T; Yamamoto, O, 1999) |
| "Procainamide is a useful agent for management of ventricular arrhythmia, however its disposition and appropriate dosing during extracorporeal membrane oxygenation (ECMO) is unknown." | 4.31 | Procainamide pharmacokinetics during extracorporeal membrane oxygenation. ( Rosenbaum, AN; Vollmer, NJ; Wieruszewski, PM; Wittwer, ED, 2023) |
| "To evaluate the effects of programmed ventricular stimulation on resultant plasma concentrations of intravenously administered procainamide, drug dosing was performed with and without ventricular stimulation on two separate days (48 hours apart) in 12 dogs (13 dosing trials) at > or = 14 days after myocardial infarction (mean: 62 days)." | 3.69 | The effects of programmed ventricular stimulation on plasma procainamide levels: an experimental model. ( Brautigam, RT; Kutalek, SP; Porter, S, 1994) |
| "Procainamide therapy was associated with less major cardiac adverse events and a higher proportion of tachycardia termination within 40 min." | 2.84 | Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. ( Almendral, J; Arribas, F; Coll-Vinent, B; Del Arco, C; Martín, A; Ortiz, M; Peinado, R, 2017) |
| "Its precise effect on the prevention of ventricular tachycardia-ventricular fibrillation (VTVF) compared to class I agents has not been evaluated in a blinded study." | 2.68 | Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group. ( Kehoe, R; Quart, B; Scheinman, M; Singh, BN; Woosley, RL, 1995) |
| "Because of VT recurrences, 16 patients could be studied repeatedly with drugs given in the reversed order." | 2.68 | Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. ( Gorgels, AP; Hofs, A; Mulleneers, R; Smeets, JL; van den Dool, A; Vos, MA; Wellens, HJ, 1996) |
| " No serious cardiac or noncardiac adverse events were noted during procainamide therapy, although there was a significant increase in the incidence of nausea." | 2.68 | Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. ( Buckley, MJ; DeSanctis, RW; Gold, MR; O'Gara, PT, 1996) |
| "The frequency-dependent electrophysiologic effects of sematilide (n = 11) and amiodarone (n = 22) were determined at (1) drug-free baseline, (2) during steady-state (> 48 hours) dosing with sematilide (455 +/- 5 mg/d [mean +/- SEM]) or after 10." | 2.67 | The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans. ( Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P, 1994) |
| "This study assessed the efficacy of the combination of sotalol and either quinidine or procainamide in preventing sustained ventricular tachycardia inducibility and recurrence and prospectively evaluated the ability of the drug combination to prevent ventricular tachycardia recurrence when the arrhythmia remained inducible but was modified." | 2.67 | Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. ( Berman, N; Dorian, P; Hardy, J; Mitchell, J; Newman, D, 1993) |
| "Procainamide is effective for stable ventricular tachycardia, and amiodarone is effective in the treatment of shock-refractory ventricular fibrillation." | 2.41 | Intravenous antiarrhythmic agents. ( Dorian, P; Pinter, A, 2001) |
| "Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy." | 2.40 | Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications. ( Aizawa, Y; Tanabe, Y; Yamaura, M, 1998) |
| "Idiopathic left ventricular tachycardia of the Belhassen type is rare in infants." | 1.42 | Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant. ( Cocalis, M; Foltz, R; Hiremath, G; Li, W; Roy-Burman, A; Tanel, RE, 2015) |
| "No arrhythmia was induced by lidocaine." | 1.40 | Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig. ( Osadchii, OE, 2014) |
| "Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) and can be difficult to treat." | 1.37 | Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. ( Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H, 2011) |
| "Procainamide was not more effective than amiodarone for the termination of sustained VT, but the ability to detect a significant difference was limited by the study design and potential confounding." | 1.36 | Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. ( deSouza, IS; Ellinor, PT; Marill, KA; Nishijima, DK; Ruskin, JN; Senecal, EL; Setnik, GS; Stair, TO, 2010) |
| "Procainamide is an antiarrhythmic drug of unproven efficacy in cardiac arrest." | 1.36 | Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest. ( Allen, J; Eisenberg, MS; Fahrenbruch, CE; Gold, LS; Kudenchuk, PJ; Markel, DT; Rea, TD, 2010) |
| "Procainamide and lidocaine were infused to equipotent plasma concentrations in canines with three-day-old myocardial infarction." | 1.32 | Spatiotemporal dynamics of reentrant ventricular tachycardias in canine myocardial infarction: pharmacological modulation. ( Cardinal, R; Hélie, F; Vinet, A, 2003) |
| "Sustained ventricular tachycardia/ventricular fibrillation (VF) was induced in 7 of 8 patients who underwent an electrophysiologic study." | 1.32 | Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan. ( Chiang, FT; Huang, SK; Juang, JM; Ko, WC; Kong, CW; Kuo, CT; Lai, LP; Lei, MH; Lin, JL; Tsai, CT; Tsao, HM; Ueng, KC; Wang, CC, 2003) |
| "We conclude that procainamide has a consistent dose-response relationship with respect to refractoriness and conduction in patients with malignant arrhythmias." | 1.31 | Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia. ( Britchkow, D; Kowey, PR; Marinchak, RA; Rials, SJ, 2000) |
| " The absolute prolongation of functional refractory periods by the drug combination increased with successive extrastimuli, from 55 +/- 6 ms for the V1V2 interval to 75 +/- 6 ms for V2V3 and 67 +/- 6 ms for V3V4 at DCL600, and from 51 +/- 5 ms for V1V2 to 69 +/- 6 ms for V2V3 and 74 +/- 7 ms for V3V4 at DCL400 (p < 0." | 1.30 | Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence. ( Dorian, P; Ham, M; Lee, SD; Newman, D, 1997) |
| "Incessant monomorphic ventricular tachycardia (VT) with a right bundle branch block morphology and a northwest axis is a rare arrhythmic complication in a patient with hypertrophic cardiomyopathy and apical left ventricular aneurysm." | 1.30 | Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy. ( Blommaert, D; de Muinck, EB; Rodriguez, LM; Smeets, JL; Timmermans, C; van Dantzig, JM; Wellens, HJ, 1997) |
| "Patient 1 had frequent episodes of paroxysmal atrial fibrillation resistant to Class IA drugs." | 1.30 | ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. ( Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M, 1999) |
| "A 70-year-old man, who had sustained ventricular tachycardias following a previous anterior myocardial infarction, suffered from skin eruptions and abnormal blood tests after 10 days following the oral administration of 1500 mg/day of procainamide." | 1.30 | [Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia]. ( Abe, H; Kohshi, K; Nakashima, Y; Numata, T; Yamamoto, O, 1999) |
| "Undersensing of ventricular tachyarrhythmias is a potentially serious problem, as it may lead to failure to deliver therapy." | 1.29 | Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming. ( Damle, RS; Kelly, PA; Mann, DE; Reiter, MJ, 1994) |
| "Although intravenously administered procainamide has been used extensively during electropharmacologic testing for more than 10 years, there is little information available on the effects of incremental dosing of procainamide in patients with inducible, monomorphic ventricular tachycardia (VT)." | 1.29 | Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia. ( Cho, JG; Grimm, W; Marchlinski, FE, 1994) |
| "The conversion of inducible polymorphic ventricular tachycardia to uniform ventricular tachycardia after procainamide administration occurs almost exclusively in patients with coronary disease, previous myocardial infarction and abnormal left ventricular function." | 1.29 | Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Miller, JM, 1993) |
| "Thus, double potentials recorded during ventricular tachycardia in these patients do not appear to represent slow conduction per se but rather appear to represent an area of block at the center of a reentrant circuit around which the reentrant wave front circulates." | 1.29 | Characterization of double potentials during ventricular tachycardia. Studies during transient entrainment. ( Moreira, D; Olshansky, B; Waldo, AL, 1993) |
| "He was found to have incessant ventricular tachycardia, impaired left ventricular contraction (ejection fraction 9%), and nonobstructive hypertrophic cardiomyopathy." | 1.28 | Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction. ( Fananapazir, L; McAreavey, D, 1992) |
| "Procainamide was effective (prevention of the inducibility of sustained ventricular tachycardia or prolongation of the cycle length of ventricular tachycardia by > 100 msec) in 15 of 27 drug trials." | 1.28 | Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis. ( Anderson, MH; Bashir, Y; Camm, AJ; Gibson, S; Heald, S; Kulakowski, P; Malik, M; Paul, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 73 (51.05) | 18.7374 |
| 1990's | 50 (34.97) | 18.2507 |
| 2000's | 10 (6.99) | 29.6817 |
| 2010's | 9 (6.29) | 24.3611 |
| 2020's | 1 (0.70) | 2.80 |
| Authors | Studies |
|---|---|
| Vollmer, NJ | 1 |
| Wittwer, ED | 1 |
| Rosenbaum, AN | 1 |
| Wieruszewski, PM | 1 |
| Mohamed, AN | 1 |
| Abdelhady, AM | 1 |
| Spencer, D | 1 |
| Sowinski, KM | 1 |
| Tisdale, JE | 1 |
| Overholser, BR | 1 |
| Osadchii, OE | 1 |
| Hiremath, G | 1 |
| Li, W | 1 |
| Foltz, R | 1 |
| Roy-Burman, A | 1 |
| Cocalis, M | 1 |
| Tanel, RE | 1 |
| Ortiz, M | 1 |
| Martín, A | 1 |
| Arribas, F | 1 |
| Coll-Vinent, B | 1 |
| Del Arco, C | 1 |
| Peinado, R | 1 |
| Almendral, J | 1 |
| Long, B | 1 |
| Koyfman, A | 1 |
| Komura, S | 1 |
| Chinushi, M | 4 |
| Furushima, H | 2 |
| Hosaka, Y | 1 |
| Izumi, D | 1 |
| Iijima, K | 1 |
| Watanabe, H | 1 |
| Yagihara, N | 1 |
| Aizawa, Y | 8 |
| Marill, KA | 1 |
| deSouza, IS | 1 |
| Nishijima, DK | 1 |
| Senecal, EL | 1 |
| Setnik, GS | 1 |
| Stair, TO | 1 |
| Ruskin, JN | 1 |
| Ellinor, PT | 1 |
| Markel, DT | 1 |
| Gold, LS | 1 |
| Allen, J | 1 |
| Fahrenbruch, CE | 1 |
| Rea, TD | 1 |
| Eisenberg, MS | 1 |
| Kudenchuk, PJ | 1 |
| Hwang, HS | 1 |
| Hasdemir, C | 1 |
| Laver, D | 1 |
| Mehra, D | 1 |
| Turhan, K | 1 |
| Faggioni, M | 1 |
| Yin, H | 1 |
| Knollmann, BC | 1 |
| Igawa, M | 1 |
| Aonuma, K | 1 |
| Okamoto, Y | 1 |
| Hiroe, M | 1 |
| Hiraoka, M | 2 |
| Isobe, M | 1 |
| Hélie, F | 1 |
| Vinet, A | 1 |
| Cardinal, R | 1 |
| Juang, JM | 1 |
| Huang, SK | 2 |
| Tsai, CT | 1 |
| Chiang, FT | 1 |
| Lin, JL | 1 |
| Lai, LP | 1 |
| Wang, CC | 1 |
| Kuo, CT | 1 |
| Ueng, KC | 1 |
| Kong, CW | 1 |
| Ko, WC | 1 |
| Lei, MH | 1 |
| Tsao, HM | 1 |
| GAQUIERE, A | 1 |
| MOTTU, T | 1 |
| BERTHOUD, E | 1 |
| DELANOE, G | 1 |
| MACDONALD, AC | 1 |
| LAZARUS, S | 1 |
| BARR, G | 1 |
| AUBERTIN, E | 1 |
| BLANCHOT, P | 1 |
| MISSON, G | 1 |
| GALL, G | 1 |
| EPSTEIN, MA | 1 |
| RAYNAUD, R | 1 |
| BERNASCONI, P | 1 |
| HOOGENBOOM, CM | 1 |
| MATTOLI, G | 1 |
| ATLANTE, G | 1 |
| MORRIS, GM | 1 |
| FRANKLIN, RB | 1 |
| LOVELACE, RE | 1 |
| WALKER, GD | 1 |
| CAMERINI, F | 1 |
| BERNSTEIN, LM | 1 |
| PASCALE, LR | 1 |
| SCHOOLMAN, HM | 1 |
| FOLEY, EF | 1 |
| MOSEY, L | 1 |
| TYLER, MD | 1 |
| ZUIDEMA, PJ | 1 |
| LEVY, G | 2 |
| ROSAIA, LR | 1 |
| ARIONI, G | 1 |
| TENENBAUM, B | 1 |
| GIORDANO, G | 1 |
| CORAGGIO, F | 1 |
| TURRISI, E | 1 |
| EMBREE, LJ | 1 |
| LEVINE, SA | 1 |
| GRATTON, JD | 1 |
| FOURNIER, G | 1 |
| KOKOWICZ, RJ | 1 |
| VIGLIERCIO, GM | 1 |
| WRIGHT, HC | 1 |
| DAVIS, RK | 1 |
| ASHFORTH, M | 1 |
| BALL, K | 1 |
| PHEAR, D | 1 |
| STEIN, WG | 1 |
| SACOLICK, SL | 1 |
| FRIEDBERG, CK | 1 |
| KRAVETZ, RE | 1 |
| KAGAN, A | 1 |
| FREMONT, RE | 1 |
| FORTIN, P | 1 |
| BJERKELUND, C | 1 |
| JAKOBSEN, E | 1 |
| UNDERHILL, WL | 1 |
| TREDWAY, JB | 1 |
| PAVESI, V | 1 |
| BIANCHI, G | 1 |
| DIXON, JK | 1 |
| SIKORAV, H | 1 |
| CAVAILLES, J | 1 |
| KELLEY, RT | 2 |
| PINAR, S | 1 |
| HOMOLA, D | 1 |
| EDELSTEIN, MM | 1 |
| PORTE, D | 1 |
| DUFFY, RW | 1 |
| NATHAN, A | 1 |
| MACKENZIE, GJ | 1 |
| PASCUAL, S | 1 |
| YAHINI, JH | 1 |
| ZAHAVI, I | 1 |
| NEUFELD, HN | 1 |
| SHALAN, LJ | 1 |
| WALPIN, L | 1 |
| RUBIN, IL | 1 |
| SCHUERHOLZ, K | 1 |
| FOLDENAUER, A | 1 |
| STUMPF, P | 1 |
| BOEHM, P | 1 |
| ERAKLIS, AJ | 1 |
| GREEN, WT | 1 |
| WATSON, CG | 1 |
| SEGALL, HN | 1 |
| HORLICK, L | 1 |
| PINE, HL | 1 |
| FOX, L | 1 |
| SHOOK, DM | 1 |
| GALLAVARDIN, L | 1 |
| SAINT-PIERRE, A | 1 |
| FROMENT, A | 1 |
| COLAS, A | 1 |
| HOFMANN, H | 1 |
| CAPONE-BRAGA, M | 1 |
| POZZI, LL | 1 |
| HOVEID, P | 1 |
| MORTIMER, EA | 1 |
| RAKITA, L | 1 |
| LAABAN, J | 1 |
| SCHNECK, G | 1 |
| IRVIN, CW | 1 |
| CUTTS, FB | 1 |
| CHARLIER, R | 2 |
| KLUTZ, A | 2 |
| VEDOYA, R | 1 |
| GARIBOTTO, RC | 1 |
| CULOGA, AP | 1 |
| ANDERSON, RM | 1 |
| BOONE, JA | 1 |
| COLEMAN, RR | 1 |
| HAMILTON, CI | 1 |
| WILSON, FW | 1 |
| SIGUIER, F | 2 |
| WELTI, JJ | 2 |
| DOSCHERHOLMEN, A | 1 |
| FISCHBACH, K | 1 |
| GOLDBERG, LI | 1 |
| COTTEN, MD | 1 |
| HANENSON, IB | 1 |
| KAYDEN, HJ | 1 |
| MESSINGER, WJ | 1 |
| LEEDHAM, CL | 1 |
| ISHAM, WH | 1 |
| HARRIS, AS | 1 |
| ESTANDIA, A | 1 |
| FORD, TJ | 1 |
| SMITH, HT | 1 |
| OLSEN, RW | 1 |
| TILLOTSON, RF | 1 |
| SCHREINER, GE | 1 |
| CASE, RB | 1 |
| KERR, MD | 1 |
| CHAPMAN, RA | 1 |
| ANTZIS, E | 1 |
| DUNN, JJ | 1 |
| SCHILERO, AJ | 1 |
| MAHAIM, I | 1 |
| DE PREUX, R | 1 |
| SIEGEL, P | 1 |
| SCHIFF, J | 1 |
| Schreibman, DS | 1 |
| McPherson, CA | 1 |
| Rosenfeld, LE | 1 |
| Batsford, WP | 1 |
| Lampert, R | 1 |
| Gever, MP | 1 |
| Joshi, S | 1 |
| Raiszadeh, F | 1 |
| Pierce, W | 1 |
| Steinberg, JS | 1 |
| Yamawake, N | 1 |
| Nishizaki, M | 1 |
| Hayashi, T | 1 |
| Niki, S | 1 |
| Maeda, S | 1 |
| Tanaka, Y | 1 |
| Fujii, H | 1 |
| Ashikaga, T | 1 |
| Sakurada, H | 1 |
| Letsas, KP | 1 |
| Gavrielatos, G | 1 |
| Efremidis, M | 1 |
| Sideris, A | 1 |
| Kardaras, F | 1 |
| Cui, G | 1 |
| Sen, L | 1 |
| Sager, P | 1 |
| Uppal, P | 2 |
| Singh, BN | 3 |
| Allen, NM | 1 |
| Page, RL | 1 |
| Klein, H | 1 |
| Trappe, HJ | 1 |
| Fieguth, HG | 1 |
| Nisam, S | 1 |
| Biblo, LA | 1 |
| Carlson, MD | 1 |
| Waldo, AL | 2 |
| Kehoe, R | 1 |
| Woosley, RL | 1 |
| Scheinman, M | 1 |
| Quart, B | 1 |
| Janssen, JH | 1 |
| Naitoh, N | 2 |
| Washizuka, T | 1 |
| Kitazawa, H | 1 |
| Takahashi, K | 1 |
| Kodama, I | 1 |
| Shibata, A | 3 |
| Meldon, SW | 1 |
| Brady, WJ | 1 |
| Berger, S | 1 |
| Mannenbach, M | 1 |
| Sager, PT | 2 |
| Follmer, C | 1 |
| Pruitt, C | 2 |
| Godfrey, R | 2 |
| Mann, DE | 1 |
| Kelly, PA | 1 |
| Damle, RS | 1 |
| Reiter, MJ | 1 |
| Grimm, W | 1 |
| Cho, JG | 1 |
| Marchlinski, FE | 2 |
| Pires, LA | 1 |
| Wagshal, AB | 1 |
| Greene, TO | 1 |
| Mittleman, RS | 1 |
| Salama, G | 1 |
| Kanai, A | 1 |
| Efimov, IR | 1 |
| Brautigam, RT | 2 |
| Porter, S | 1 |
| Kutalek, SP | 2 |
| Fiksinski, E | 1 |
| Martin, D | 1 |
| Venditti, F | 1 |
| Peters, RW | 1 |
| Kim, HJ | 1 |
| Buser, GA | 1 |
| Gold, MR | 3 |
| Makkar, RR | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
| Shinmura, K | 1 |
| Hasegawa, H | 1 |
| Ishida, H | 1 |
| Shimizu, K | 1 |
| Ebihara, Y | 1 |
| Koyama, T | 1 |
| Iwanaga, S | 1 |
| Honma, S | 1 |
| Tani, M | 1 |
| Handa, S | 1 |
| Nademanee, K | 1 |
| Antimisiaris, M | 1 |
| Pacifico, A | 1 |
| Buxton, AE | 1 |
| Josephson, ME | 2 |
| Miller, JM | 1 |
| Kidwell, GA | 1 |
| Greenspon, AJ | 1 |
| Greenberg, RM | 1 |
| Volosin, KJ | 1 |
| Olshansky, B | 2 |
| Moreira, D | 1 |
| Markel, ML | 1 |
| Miles, WM | 1 |
| Luck, JC | 1 |
| Klein, LS | 1 |
| Prystowsky, EN | 1 |
| Kulakowski, P | 2 |
| Bashir, Y | 2 |
| Heald, S | 2 |
| Paul, V | 2 |
| Anderson, MH | 2 |
| Gibson, S | 2 |
| Malik, M | 2 |
| Camm, AJ | 2 |
| Dorian, P | 3 |
| Newman, D | 2 |
| Berman, N | 1 |
| Hardy, J | 1 |
| Mitchell, J | 1 |
| Miyazaki, T | 1 |
| Mitamura, H | 1 |
| Miyoshi, S | 1 |
| Soejima, K | 1 |
| Ogawa, S | 1 |
| Ebe, K | 1 |
| Gorgels, AP | 1 |
| van den Dool, A | 1 |
| Hofs, A | 1 |
| Mulleneers, R | 1 |
| Smeets, JL | 2 |
| Vos, MA | 1 |
| Wellens, HJ | 2 |
| O'Gara, PT | 1 |
| Buckley, MJ | 1 |
| DeSanctis, RW | 1 |
| Lee, SD | 1 |
| Ham, M | 1 |
| Rodriguez, LM | 1 |
| Timmermans, C | 1 |
| Blommaert, D | 1 |
| van Dantzig, JM | 1 |
| de Muinck, EB | 1 |
| Holzberger, PT | 1 |
| Greenberg, ML | 1 |
| Paicopolis, MC | 1 |
| Ozahowski, TP | 1 |
| Ho, PC | 1 |
| O'Connor, GT | 1 |
| Tanabe, Y | 1 |
| Yamaura, M | 1 |
| Ohira, K | 1 |
| Niwano, S | 1 |
| Taneda, K | 1 |
| Fujiki, A | 1 |
| Usui, M | 1 |
| Nagasawa, H | 1 |
| Mizumaki, K | 1 |
| Hayashi, H | 1 |
| Inoue, H | 1 |
| Trohman, RG | 1 |
| Sahu, J | 1 |
| Kavesh, NG | 1 |
| Shorofsky, SR | 1 |
| Sarang, SE | 1 |
| Girard, SE | 1 |
| Munger, TM | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Kim, YH | 2 |
| Yashima, M | 2 |
| Wu, TJ | 2 |
| Doshi, R | 1 |
| Chen, PS | 2 |
| Karagueuzian, HS | 2 |
| Xie, F | 1 |
| Valderrábano, M | 1 |
| Lee, MH | 1 |
| Ohara, T | 1 |
| Voroshilovsky, O | 1 |
| Doshi, RN | 1 |
| Fishbein, MC | 1 |
| Qu, Z | 1 |
| Garfinkel, A | 1 |
| Weiss, JN | 1 |
| Numata, T | 1 |
| Abe, H | 1 |
| Nakashima, Y | 1 |
| Yamamoto, O | 1 |
| Kohshi, K | 1 |
| Rials, SJ | 1 |
| Britchkow, D | 1 |
| Marinchak, RA | 1 |
| Kowey, PR | 1 |
| Pinter, A | 1 |
| Verrostte, JM | 1 |
| van Hemel, NM | 1 |
| Kingma, JH | 1 |
| McAreavey, D | 1 |
| Fananapazir, L | 1 |
| Schuster, M | 1 |
| Porter, RS | 1 |
| Nydegger, C | 1 |
| Guo, Z | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000518] | Phase 3 | 0 participants | Interventional | 1985-07-31 | Completed | ||
| Non-invasive Programmed Stimulation to Identify High-risk Patients With Implanted Cardioverter-defibrillator[NCT02373306] | 150 participants (Anticipated) | Interventional | 2013-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for procainamide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, H | 2017 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiogra | 1998 |
Intravenous antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Procainamid | 2001 |
13 trials available for procainamide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Drug Administration Schedule; Female; Hu | 2017 |
Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Female; | 2010 |
Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Hemodynamics; Humans; M | 2002 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow- | 1994 |
Prospective studies evaluating prophylactic ICD therapy for high risk patients with coronary artery disease.
Topics: Aged; Coronary Disease; Defibrillators, Implantable; Electrocardiography; Heart Arrest; Humans; Male | 1993 |
Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Bias; Cardiac Pacing, Artificial; Drug Combinations; Electrocardiography, Am | 1995 |
Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Double-Blind Method; Elec | 1995 |
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Ele | 1994 |
Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Ma | 1993 |
Clinical characteristics and EPS-guided therapy in 142 cases of sustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Disopyramide; Electrophy | 1996 |
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Male | 1996 |
Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Coronary Disease; Delaye | 1996 |
Comparison of intravenous dosing regimens for maintaining steady-state procainamide levels during programmed ventricular stimulation.
Topics: Acecainide; Cardiac Pacing, Artificial; Humans; Immunoenzyme Techniques; Infusions, Intravenous; Inj | 1992 |
126 other studies available for procainamide and Tachycardia, Ventricular
| Article | Year |
|---|---|
Procainamide pharmacokinetics during extracorporeal membrane oxygenation.
Topics: Acecainide; Adult; Arrhythmias, Cardiac; Extracorporeal Membrane Oxygenation; Humans; Procainamide; | 2023 |
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments.
Topics: Acecainide; Adult; Anti-Arrhythmia Agents; Humans; Male; Models, Biological; Procainamide; Renal Ins | 2013 |
Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Femal | 2014 |
Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant.
Topics: Adenosine; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Female; Heart Ventricle | 2015 |
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Administration Schedule; Electrocardi | 2010 |
Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest.
Topics: Aged; Anti-Arrhythmia Agents; Confounding Factors, Epidemiologic; Female; Heart Arrest; Humans; Logi | 2010 |
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defi | 2011 |
Spatiotemporal dynamics of reentrant ventricular tachycardias in canine myocardial infarction: pharmacological modulation.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; Heart Rate; In Vitro Techniques; | 2003 |
Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan.
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Catheterization; China; Coronary Angiography; Echocardiograph | 2003 |
[Benign ventricular paroxysmal tachycardia in a child and arrested with pronestyl].
Topics: Child; Heart Arrest; Humans; Infant; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; T | 1952 |
[Pronestyl therapy in crises of ventricular tachycardia].
Topics: Cardiovascular Diseases; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, | 1952 |
[Attack of ventricular tachycardia; recovery after intravenous injection of procaine amide].
Topics: Animals; Behavior, Animal; Injections, Intravenous; Procainamide; Procaine; Social Behavior; Tachyca | 1952 |
Paroxysmal supra-ventricular tachycardia: report of a case in which procaine amide was effectively used after failure with quinidine.
Topics: Electrocardiography; Procainamide; Procaine; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Tachyc | 1953 |
[Terminal ventricular tachycardia with auricular fibrillation in mitral stenosis; failure of procaine amide].
Topics: Atrial Fibrillation; Cardiovascular Diseases; Constriction, Pathologic; Mitral Valve; Mitral Valve S | 1952 |
Ventricular standstill during the intravenous procaine amide treatment of ventricular tachycardia.
Topics: Administration, Intravenous; Heart Ventricles; Humans; Procainamide; Procaine; Tachycardia; Tachycar | 1953 |
[Ventricular tachycardia after procaine amide injection].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1953 |
[Electrocardiographic findings after intravenous administration of procaine-amide (pronestyl) in paroxysmal ventricular tachycardia].
Topics: Administration, Intravenous; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Tachycard | 1953 |
[Repeated attacks of paroxysmal ventricular tachycardia controlled by procaine amide with quinidine].
Topics: Humans; Procainamide; Quinidine; Social Behavior; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, | 1953 |
Ventricular tachycardia due to idiopathic pericarditis controlled by simultaneous intravenous procaine amide and quinidine.
Topics: Cardiovascular Diseases; Humans; Pericarditis; Procainamide; Quinidine; Tachycardia; Tachycardia, Ve | 1954 |
Resistant ventricular tachycardia cured with large doses of procainamide.
Topics: Electrocardiography; Heart Failure; Humans; Procainamide; Tachycardia; Tachycardia, Ventricular | 1954 |
[Case of paroxysmal ventricular tachycardia resistant to quinidine and sensitive to procaine amide: consecutive modifications of blood proteins and glycemia and post-tachycardial syndrome].
Topics: Blood Glucose; Blood Proteins; Humans; Procainamide; Quinidine; Syndrome; Tachycardia; Tachycardia, | 1954 |
Intravenous procaine amide as an aid to differentiate auricular flutter with bundle branch block from paroxysmal ventricular tachycardia.
Topics: Atrial Flutter; Bundle-Branch Block; Cardiac Conduction System Disease; Diagnosis, Differential; Ele | 1954 |
The effect of diphenylhydantoin sodium (dilantin), procaine hydrochloride, procaine amide hydrochloride, and quinidine hydrochloride upon ouabain-induced ventricular tachycardia in unanesthetized dogs.
Topics: Animals; Dogs; Hydantoins; Ouabain; Phenytoin; Procainamide; Procaine; Quinidine; Sodium; Tachycardi | 1954 |
[Transient cardiac arrest after intravenous administration of procaine amide in paroxysmal ventricular tachycardia].
Topics: Administration, Intravenous; Heart Arrest; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachy | 1954 |
[Pronestyl treatment of ventricular tachycardia in young child].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1956 |
[Pronestyl treatment of ventricular tachycardia in young child].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1956 |
[Pronestyl treatment of ventricular tachycardia in young child].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1956 |
[Pronestyl treatment of ventricular tachycardia in young child].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1956 |
[Ventricular paroxysmal tachycardia after myocardial infarct and definitely checked by 10 pronestyl tablets].
Topics: Humans; Myocardial Infarction; Procainamide; Tablets; Tachycardia; Tachycardia, Paroxysmal; Tachycar | 1957 |
[Ventricular tachycardia in young child; treatment with pronestyl].
Topics: Cardiovascular Diseases; Child; Humans; Infant; Procainamide; Tachycardia; Tachycardia, Ventricular | 1957 |
[Ventricular paroxysmal tachycardia after myocardial infarct; efficacy of the treatment].
Topics: Humans; Myocardial Infarction; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Tachyc | 1958 |
[Treatment of ventricular tachycardia with the procaine amide pronestyl].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1958 |
[Post-infarction ventricular paroxysmal tachycardia; recurrent attacks at first controlled with procaine amide and thereafter definitively blocked with sparteine iodomethylate].
Topics: Infarction; Myocardial Infarction; Procainamide; Social Behavior; Sparteine; Tachycardia; Tachycardi | 1958 |
Ventricular tachycardia: a case requiring massive amounts of procaine amide (pronestyl) for reversion.
Topics: Cardiovascular Diseases; Procainamide; Tachycardia; Tachycardia, Ventricular | 1959 |
[Paroxysmal ventricular tachycardia following myocardial infarct & definitely arrested by 10 pronestyl tablets; follow-up on the patient 4 years later].
Topics: Follow-Up Studies; Humans; Myocardial Infarction; Plastics; Procainamide; Tablets; Tachycardia; Tach | 1959 |
[Ventricular tachycardia].
Topics: Cardiovascular Diseases; Procainamide; Tachycardia, Ventricular | 1961 |
Intractable ventricular tachycardia. Unusual mode of conversion to normal rhythm following intravenous procaine amide.
Topics: Cardiovascular Diseases; Humans; Procainamide; Tachycardia; Tachycardia, Ventricular | 1961 |
[Ventricular paroxysmal tachycardia treated by procamide with immediate beneficial effect].
Topics: Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1960 |
Persistent ventricular tachycardia. Report of a case successfully treated with very large intravenous doses of procaine amide.
Topics: Cardiovascular Diseases; Humans; Procainamide; Tachycardia; Tachycardia, Ventricular | 1961 |
The treatment of paroxysmal ventricular tachycardia with procaine amide.
Topics: Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1959 |
Critical evaluation of indications for external electric countershock in the treatment of ventricular tachycardia.
Topics: Cardiovascular Diseases; Electric Countershock; Electric Stimulation Therapy; Humans; Procainamide; | 1963 |
Termination of rapid ventricular tachycardia with metaraminol (Aramine).
Topics: Humans; Lanatosides; Metaraminol; Myocardial Infarction; Procainamide; Tachycardia; Tachycardia, Ven | 1962 |
[VENTRICULAR TACHYCARDIA. (DIAGNOSIS AND TREATMENT)].
Topics: Digitalis Glycosides; Electric Countershock; Electric Stimulation Therapy; Electrocardiography; Hydr | 1963 |
[VENTRICULAR TACHYCARDIA].
Topics: Atrial Fibrillation; Blood Pressure Determination; Coronary Disease; Electrocardiography; Geriatrics | 1964 |
THE TREATMENT OF PAROXYSMAL VENTRICULAR TACHYCARDIA WITH ISOPROTERENOL.
Topics: Electrocardiography; Infusions, Parenteral; Isoproterenol; Procainamide; Quinidine; Tachycardia; Tac | 1964 |
[PAROXYSMAL VENTRICULAR TACHYCARDIA IN THE COURSE OF TOTAL ATRIO-VENTRICULAR BLOCK WITH ADAMS-STOKES SYNDROME. DESCRIPTION OF A CLINICAL CASE AND PREVENTIVE EFFICACY OF PROCAINE THERAPY IN PROTRACTED VENOUS PERFUSION].
Topics: Adams-Stokes Syndrome; Electrocardiography; Ephedrine; Geriatrics; Heart Block; Infusions, Parentera | 1964 |
REFRACTORY VENTRICULAR TACHYCARDIA: REPORT OF A PATIENT SUCCESSFULLY TREATED WITH HIGH DOSES OF QUINIDINE INTRAVENOUSLY.
Topics: Black People; Digitalis; Electrocardiography; Norepinephrine; Oxygen Inhalation Therapy; Procainamid | 1964 |
[VENTRICULAR TACHYCARDIA. DIAGNOSIS AND TREATMENT].
Topics: Electric Countershock; Electric Stimulation Therapy; Electrocardiography; Humans; Procainamide; Quin | 1964 |
VENTRICULAR TACHYCARDIA: AN AWESOME ARRHYTHMIA.
Topics: Arrhythmias, Cardiac; Blood Pressure Determination; Coronary Disease; Digitalis; Digitalis Glycoside | 1964 |
[PAROXYSMAL VENTRICULAR TACHYCARDIA WITH HEART BLOCK].
Topics: Heart Block; Isoproterenol; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventric | 1964 |
A CASE OF VENTRICULAR TACHYCARDIA INTRODUCED BY COMBINED TACHYCARDIA WITH WPW COMPLEXES AND EVOKED BY ORTHOSTASIS.
Topics: Cardiac Complexes, Premature; Dizziness; Drug Therapy; Electrocardiography; Humans; Posture; Procain | 1964 |
VENTRICULAR TACHYCARDIA OF TWENTY-TWO DAYS DURATION. TREATMENT BY EXTERNAL ELECTRIC COUNTERSHOCK.
Topics: Arteriosclerosis; Electric Countershock; Electric Stimulation Therapy; Electrocardiography; Geriatri | 1964 |
PAROXYSMAL VENTRICULAR TACHYCARDIA.
Topics: Coronary Disease; Diagnosis; Digitalis Glycosides; Electrocardiography; Heart Failure; Hydrocortison | 1964 |
PAROXYSMAL ATRIAL FIBRILLATION IN WOLFF-PARKINSON-WHITE SYNDROME SIMULATING VENTRICULAR TACHYCARDIA.
Topics: Atrial Fibrillation; Diagnosis, Differential; Digoxin; Electrocardiography; Humans; Procainamide; Pr | 1964 |
PARADOXICAL ACCELERATION OF VENTRICULAR TACHYCARDIA AFTER PROCAINE AMIDE THERAPY.
Topics: Blood Pressure Determination; Drug Therapy; Electrocardiography; Heart Conduction System; Humans; Pr | 1964 |
[TREATMENT OF VENTRICULAR TACHYCARDIA WITH ALUPENT].
Topics: Drug Therapy; Electrocardiography; Isoproterenol; Metaproterenol; Myocardial Infarction; Procainamid | 1965 |
RECURRENT PAROXYSMS OF VENTRICULAR TACHYCARDIA FOLLOWING MITRAL VALVULOPLASTY: CASE REPORT.
Topics: Cardiac Surgical Procedures; Digitalis Glycosides; Electric Countershock; Electrocardiography; Heart | 1965 |
"BENIGN" VENTRICULAR PAROXYSMAL TACHYCARDIA: OBSERVATIONS ON A CASE FOLLOWED UP FOR A 17-YEAR PERIOD, WITH SPECIAL REFERENCE TO CARDIOVASCULAR SOUND.
Topics: Cardiovascular System; Drug Therapy; Electrocardiography; Heart Auscultation; Humans; Procainamide; | 1965 |
PAROXYSMAL VENTRICULAR TACHYCARDIA COMPLICATING PREGNANCY.
Topics: Adolescent; Drug Therapy; Electrocardiography; Female; Humans; Pregnancy; Pregnancy Complications; P | 1965 |
[SUBINTRANT PAROXYSMAL VENTRICULAR TACHYCARDIA. A CASE OF EXTRAORDINARILY REFRACTORY COURSE IN A YOUNG SUBJECT. TREATMENT OF ATTACKS WITH PROCAINE AMIDE, INTRAVENOUS AJMALINE AND ELECTRIC SHOCKS].
Topics: Ajmaline; Pacemaker, Artificial; Procainamide; Rauwolfia; Tachycardia; Tachycardia, Paroxysmal; Tach | 1964 |
[Novocamid treatment of genuine ventricular paroxysmal tachycardia, with a contribution to its clinical classification].
Topics: Humans; Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1954 |
[Paroxysmal ventricular tachycardia occurring during treatment with intravenous procaine amide].
Topics: Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1953 |
[Procaine amide in prolonged therapy of paroxysmal ventricular tachycardia].
Topics: Procainamide; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1955 |
Ventricular tachycardia in childhood controlled with large doses of procaine amide.
Topics: Cardiovascular Diseases; Child; Humans; Infant; Procainamide; Tachycardia; Tachycardia, Ventricular | 1960 |
[Ventricular tachycardia. Reduction by procaine amide and hydroquinidine].
Topics: Cardiovascular Diseases; Procainamide; Procaine; Quinidine; Tachycardia; Tachycardia, Ventricular | 1962 |
Ventricular tachycardia; report of a case in which "pronestyl" was effectively used after failure with quinidine.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Procainamide; Procaine; Quinidine; Tachycardia, Ventr | 1951 |
[Experimental ventricular tachycardia. II. Experimental reversal with procaine amide and dibenzylmethylamine].
Topics: Aconitine; Arrhythmias, Cardiac; Cardiovascular Diseases; Humans; Phenethylamines; Procainamide; Tac | 1951 |
[Comparison of effects of quinidine and procaine amide (pronestyl) in a case of ventricular tachycardia].
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Procainamide; Procaine; Quinidine; Tachycardia, Ventr | 1951 |
The use of procaine amide in ventricular tachycardia.
Topics: Cardiovascular Diseases; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular | 1951 |
The treatment of paroxysmal ventricular tachycardia with pronestyl.
Topics: Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1951 |
[Procaine amide in the treatment of ventricular paroxysmal tachycardia and other disorders of cardiac rhythm].
Topics: Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Humans; Procainamide; Procaine; Tachyc | 1951 |
Procaine amide in the treatment of ventricular tachycardia.
Topics: Cardiovascular Diseases; Minnesota; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Ta | 1951 |
Treatment of ventricular tachycardia with procaine amide.
Topics: Cardiovascular Diseases; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular | 1952 |
[Therapy of ventricular paroxysmal tachycardia with procaine amide].
Topics: Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1951 |
Effectiveness of procaine amide in digitalis-induced ventricular tachycardia.
Topics: Digitalis; Digitalis Glycosides; Plant Extracts; Procainamide; Procaine; Tachycardia; Tachycardia, V | 1951 |
Recurrent ventricular tachycardia treated with procaine amide.
Topics: Cardiovascular Diseases; Humans; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular | 1952 |
[Experimental ventricular tachycardia. IV. Failure of protection by procaine amide].
Topics: Cardiovascular Diseases; Heart Failure; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricula | 1951 |
Pronestyl in the treatment of ventricular tachycardia.
Topics: Cardiovascular Diseases; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular | 1952 |
The effects of intravenous procaine and procaine amide (pronestyl) upon ectopic ventricular tachycardia accompanying acute myocardial infarction.
Topics: Myocardial Infarction; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular; Ventricular Pr | 1952 |
Ventricular tachycardia following procaine amide hydrochloride (pronestyl) and quinidine.
Topics: Cardiovascular Diseases; Humans; Procainamide; Procaine; Quinidine; Tachycardia; Tachycardia, Paroxy | 1952 |
Treatment of ventricular tachycardia with procaine amide.
Topics: Cardiovascular Diseases; Procainamide; Procaine; Tachycardia; Tachycardia, Ventricular | 1952 |
Use of quinidine sulfate and of procaine amide in a patient with paroxysmal ventricular tachycardia.
Topics: Procainamide; Procaine; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1952 |
Pronestyl (procaine amide) therapy in paroxysmal ventricular tachycardia.
Topics: Humans; Procainamide; Procaine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1952 |
[Severe ventricular tachycardia; sudden cardiac insufficiency; quinine unsuccessful; prompt effect of pronestyl; registration of the end of the ventricular crisis].
Topics: Heart Failure; Heart Ventricles; Procainamide; Procaine; Quinine; Tachycardia; Tachycardia, Ventricu | 1952 |
Pronestyl by continuous intravenous drip for stubborn ventricular tachycardia complicating coronary occlusion.
Topics: Cardiovascular Diseases; Coronary Occlusion; Infusions, Intravenous; Myocardial Infarction; Procaina | 1952 |
Usefulness of procainamide challenge for electrophysiologic arrhythmia risk stratification.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrophysiology; Female; Humans; Infusi | 2004 |
Procainamide: Test your drug IQ.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Interactions; Drug Monitoring; Humans; Nurse's Rol | 2006 |
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Impl | 2007 |
Autonomic and pharmacological responses of idiopathic ventricular tachycardia arising from the left ventricular outflow tract.
Topics: Adenosine Triphosphate; Anti-Arrhythmia Agents; Cardiotonic Agents; Catheter Ablation; Electrophysio | 2007 |
The natural history of arrhythmogenic right ventricular cardiomyopathy.
Topics: Aged; Bundle-Branch Block; Cardiomyopathies; Catheter Ablation; Dyspnea; Female; Heart Ventricles; H | 2007 |
Procainamide administration during pregnancy.
Topics: Acecainide; Administration, Oral; Adult; Cardiac Pacing, Artificial; Female; Humans; Pregnancy; Preg | 1993 |
Treatment of ventricular tachycardia.
Topics: Humans; Lidocaine; Procainamide; Sotalol; Tachycardia, Ventricular | 1994 |
Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Electrop | 1994 |
Pediatric ventricular tachycardia: a review with three illustrative cases.
Topics: Child, Preschool; Combined Modality Therapy; Electrocardiography; Female; Humans; Infant; Infant, Ne | 1994 |
Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
Topics: Aged; Atrial Fibrillation; Defibrillators, Implantable; Electrocardiography; Electrophysiology; Equi | 1994 |
Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Electr | 1994 |
Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Coronary Disease; Electrocardiography; | 1993 |
Subthreshold stimulation of Purkinje fibers interrupts ventricular tachycardia in intact hearts. Experimental study with voltage-sensitive dyes and imaging techniques.
Topics: Action Potentials; Animals; Cardiac Pacing, Artificial; Female; Guinea Pigs; In Vitro Techniques; Ma | 1994 |
The effects of programmed ventricular stimulation on plasma procainamide levels: an experimental model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; My | 1994 |
Electrical proarrhythmia with procainamide: a new ICD-drug interaction.
Topics: Aged; Defibrillators, Implantable; Disopyramide; Humans; Male; Mexiletine; Procainamide; Tachycardia | 1994 |
Ischemically mediated sustained monomorphic ventricular tachycardia. Resolution with anti-ischemic therapy.
Topics: Coronary Angiography; Diltiazem; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide | 1993 |
[Lethal arrhythmias in a patient with coarctation of the aorta and severe heart failure: their control by combination of low dose amiodarone with procainamide for 3 years].
Topics: Administration, Oral; Adult; Amiodarone; Aortic Coarctation; Drug Therapy, Combination; Heart Failur | 1993 |
Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Heart Conductio | 1993 |
Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide.
Topics: Cardiac Pacing, Artificial; Drug Evaluation; Electrocardiography; Electrophysiology; Female; Follow- | 1993 |
Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Mal | 1993 |
Characterization of double potentials during ventricular tachycardia. Studies during transient entrainment.
Topics: Aged; Cardiac Pacing, Artificial; Electrophysiology; Female; Heart Conduction System; Humans; Male; | 1993 |
Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiac Pacing, Artificial; Drug Therapy, Comb | 1993 |
Effects of procainamide on the signal-averaged electrocardiogram in relation to the results of programmed ventricular stimulation in patients with sustained monomorphic ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Chronic Disease; Electrocardiography; Humans; Male; Middle Aged; P | 1993 |
Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Humans; | 1996 |
Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disopyramide; Drug Administration S | 1996 |
Lidocaine and sustained monomorphic ventricular tachycardia: fact or fiction.
Topics: Anti-Arrhythmia Agents; Humans; Infusions, Intravenous; Lidocaine; Procainamide; Tachycardia, Ventri | 1996 |
Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
Topics: Action Potentials; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Therapy, Combination; El | 1997 |
Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Catheter Ablation; Electric Stimulation; | 1997 |
Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
Topics: Aged; Anti-Arrhythmia Agents; Electrophysiology; Female; Follow-Up Studies; Hemodynamics; Humans; In | 1998 |
The use of the block cycle length as a safe and efficient means of interrupting sustained ventricular tachycardia and its pharmacological modification.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac | 1998 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Hea | 1999 |
Drug-induced torsade de pointes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Arrest; Humans; Male; Procainam | 1999 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinica | 1998 |
The effect of procainamide on T wave alternans.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Ma | 1999 |
The effect of intravenous procainamide on the HV interval at electrophysiologic study.
Topics: Aged; Arrhythmias, Cardiac; Electrophysiology; Female; Heart; Heart Arrest, Induced; Humans; Injecti | 1999 |
Mechanism of procainamide-induced prevention of spontaneous wave break during ventricular fibrillation. Insight into the maintenance of fibrillation wave fronts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; | 1999 |
Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle.
Topics: Animals; Anti-Arrhythmia Agents; Computer Simulation; Electronic Data Processing; Electrophysiology; | 1999 |
[Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia].
Topics: Aged; Anti-Arrhythmia Agents; Disseminated Intravascular Coagulation; Drug Eruptions; Humans; Male; | 1999 |
Electropharmacologic effect of a standard dose of intravenous procainamide in patients with sustained ventricular tachycardia.
Topics: Aged; Anti-Arrhythmia Agents; Bundle of His; Dose-Response Relationship, Drug; Electrophysiology; Fe | 2000 |
Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrioventric | 1990 |
Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Electrocardiography; Humans; Male; Pacemaker, Artif | 1992 |
Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conduction Sy | 1992 |
[Actions of antiarrhythmic drug on the reentrant circuit of sustained ventricular tachycardia].
Topics: Electrocardiography; Electrophysiology; Heart Conduction System; Humans; Procainamide; Tachycardia, | 1992 |
[Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias].
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Benzylisoquinolines; Dogs; Drugs, Chinese Herbal; Electr | 1992 |